Table 2. Distribution of breast cancer patients according to pathological characteristics.
Pathological features | Breast cancer | |
---|---|---|
n | % | |
Tumour grade | ||
I | 04 | 13.3 |
II | 12 | 40.0 |
III | 14 | 46.7 |
Tumour size | ||
< 2 cm | 12 | 40 |
≥ 2 cm | 18 | 60 |
Histologycal type | ||
Ductal in situ | 01 | 3.3 |
Invasive ductal | 29 | 96.7 |
Hormone receptor status | ||
ER | ||
Positive | 15 | 50 |
Negative | 15 | 50 |
PR | ||
Positive | 17 | 56.7 |
Negative | 13 | 43.3 |
HER2 | ||
Positive | 6 | 20 |
Negative | 24 | 80 |
Molecular subtypes | ||
Luminal A | 03 | 10.0 |
Luminal B | 16 | 53.3 |
HER2+ | 03 | 10.0 |
Triple negative | 08 | 26.7 |
Abbreviations: ER: estrogen receptor, PR: progesterone receptor, HER2: human epidermal growth factor receptor-type 2.